摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲胺基-3-吡啶甲酸 | 32399-13-6

中文名称
2-甲胺基-3-吡啶甲酸
中文别名
2-(甲基氨基)-3-吡啶羧酸;2-甲氨基-3-吡啶羧酸;艾沙康唑中间体5
英文名称
2-(methylamino)pyridine-3-carboxylic acid
英文别名
2-(methylamino)nicotinic acid
2-甲胺基-3-吡啶甲酸化学式
CAS
32399-13-6
化学式
C7H8N2O2
mdl
MFCD00128789
分子量
152.153
InChiKey
SMYTUBMIBZOXTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    250-255°C
  • 沸点:
    336.5±27.0 °C(Predicted)
  • 密度:
    1.327±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    62.2
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2933399090
  • 储存条件:
    应存放在室温、密闭且干燥的环境中。

SDS

SDS:1be597ec0f1f59080bebaaf9b1df68c6
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 2-(Methylamino)pyridine-3-carboxylic acid
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 32399-13-6
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Skin sensitisation (Category 1), H317
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R43
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H317 May cause an allergic skin reaction.
Precautionary statement(s)
P280 Wear protective gloves.
Supplemental Hazard none
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Synonyms : 2-Methylaminonicotinic acid
Formula : C7H8N2O2
Molecular Weight : 152,15 g/mol
CAS-No. : 32399-13-6
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
2-(Methylamino)pyridine-3-carboxylic acid
Skin Sens. 1; H317 -
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
2-(Methylamino)pyridine-3-carboxylic acid
Xi, R43 -
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 250 - 255 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 0,446
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-甲胺基-3-吡啶甲酸N,N'-羰基二咪唑 、 sodium tetrahydroborate 作用下, 以 四氢呋喃 为溶剂, 以88 %的产率得到2-甲胺基-3-吡啶甲醇
    参考文献:
    名称:
    2-甲胺基-3-羟甲基吡啶的制备方法
    摘要:
    本发明提供了一种2‑甲胺基‑3‑吡啶甲醇及艾沙康唑鎓硫酸盐的新的制备工艺,具体采用将2‑甲胺‑3‑吡啶羧酸在辅助试剂存在条件下通过NaBH4还原,制备得到2‑甲胺基‑3‑吡啶甲醇,本发明所述的方法利用羧酸原位条件下转化为活性酯的中间体,再使用相对温和的还原剂NaBH4对活性酯中间体进行还原得到了对应的醇类产物,避免了危险性高的还原剂的使用,以及剧毒化合物硼烷的产生,大大提供生产安全性,并显著降低生产成本。
    公开号:
    CN115772121A
  • 作为产物:
    描述:
    2-甲胺基-3-吡啶甲醇2,2,6,6-四甲基哌啶氧化物 、 sodium bromide 、 sodium hydroxide 、 sodium hypochlorite 作用下, 以 1,2-二氯乙烷丙酮 为溶剂, 生成 2-甲胺基-3-吡啶甲酸
    参考文献:
    名称:
    自动机器学习辅助 TEMPO 催化伯醇氧化制备羧酸
    摘要:
    尽管醇氧化被认为是成熟的反应,但选择生产条件或预测未见醇的反应产率仍然是主要挑战。在此,公开了一种用于将伯醇催化氧化为相应羧酸的自动机器学习 (ML) 模型。使用高通量实验 (HTE) 生成了包含 3444 个数据的数据集,其中包含 282 种伯醇和 45 种条件。使用 HTE 数据和 105 个描述符,使用 AutoGluon(开源自动机器学习框架)和 KNIME(开源数据分析平台)执行多标签预测。对于 240 次反应的独立测试(20 种未见醇和 12 种条件的完整矩阵),AutoGluon 和用于产量预测的多标签预测 (AGMP) 表现出色。R 2为0.767,MAE为4.9%。该模型还表明,新生成的描述符(Y/N,反应反应性分类)是与产量预测最相关的描述符,为将 HTE 和 ML 集成到有机合成中提供了新的视角。
    DOI:
    10.1002/cjoc.202200555
点击查看最新优质反应信息

文献信息

  • [EN] HEXAHYDRO-1H-PYRAZINO[1,2-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE<br/>[FR] COMPOSÉS HEXAHYDRO-1H-PYRAZINO[1,2-A]PYRAZINE POUR LE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2020207991A1
    公开(公告)日:2020-10-15
    The present invention relates to compounds of formula (I), wherein R1 to R3, n and A are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    本发明涉及式(I)的化合物,其中R1至R3,n和A如本文所述,以及其药学上可接受的盐,以及包括这些化合物的组合物和使用这些化合物的方法。
  • [EN] INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS D'INDOLÉAMINE 2,3-DIOXYGÉNASE ET LEURS PROCÉDÉS D'UTILISATION
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2019136112A1
    公开(公告)日:2019-07-11
    The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed.
    本发明提供了一种化合物,其化学式为(II):一种吲哌酮胺2,3-二氧化酶(IDO)抑制剂,可用作治疗增生性疾病,如癌症、病毒感染和/或自身免疫疾病的药物。其前药也已被披露。
  • [EN] HYDROPYRAZINO[1,2-D][1,4]DIAZEPINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE<br/>[FR] COMPOSÉS D'HYDROPYRAZINO[1,2-D][1,4]DIAZÉPINE POUR LE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2021084022A1
    公开(公告)日:2021-05-06
    The present invention relates to compounds of formula (I), wherein R1 to R3 and n are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    本发明涉及式(I)的化合物,其中R1至R3和n如本文所述,以及其药学上可接受的盐,以及包括这些化合物的组合物和使用这些化合物的方法。
  • [EN] 6,6-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR<br/>[FR] MODULATEURS ALLOSTÉRIQUES D'ÉTHER DE PIPÉRIDINE D'HÉTÉROARYLE 6,6-FUSIONNÉ DU RÉCEPTEUR MUSCARINIQUE M4 DE L'ACÉTYLCHOLINE
    申请人:MERCK SHARP & DOHME
    公开号:WO2018118735A1
    公开(公告)日:2018-06-28
    The present invention is directed to 6,6-fused heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.
    本发明涉及6,6-融合杂环哌啶醚化合物,这些化合物是M4肌氨酸乙酰胆碱受体的变构调节剂。本发明还涉及所述化合物在潜在的治疗或预防M4肌氨酸乙酰胆碱受体参与的神经和精神障碍和疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗M4肌氨酸乙酰胆碱受体参与的疾病中的用途。
  • RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES
    申请人:Takabe Fumiaki
    公开号:US20110287937A1
    公开(公告)日:2011-11-24
    Provided are 2-pyridone derivatives which have excellent herbicidal activity and exhibit high safety to useful crops and so on; salts thereof; and herbicides containing same. In more detail, 2-pyridone derivatives represented by general formula [I] or agrochemically acceptable salts thereof, and herbicides containing these compounds are provided. In general formula [I], X 1 is an oxygen atom or a sulfur atom; X 2 , X 3 , and X 4 are to each CH or N(O) m ; m is an integer of 0 or 1; R 1 is a hydrogen atom, a C 1-12 alkyl group, or the like; R 2 is a halogen atom, a cyano group, or the like; n is an integer of 0 to 4; R 3 is a hydroxyl group, a halogen atom, or the like; A 1 is C(R 11 R 12 ); A 2 is C(R 13 R 14 ) or C═O; A 3 is C(R 15 R 16 ); and R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 are each independently a hydrogen atom or a C 1-6 alkyl group.
    提供了具有优异除草活性并对有用作物等表现出高安全性的2-吡啶酮衍生物;其盐;以及含有这些化合物的除草剂。更详细地说,提供了通式[I]所表示的2-吡啶酮衍生物或其农药可接受的盐,以及含有这些化合物的除草剂。在通式[I]中,X1是氧原子或硫原子;X2、X3和X4分别为CH或N(O)m;m是0或1的整数;R1是氢原子,C1-12烷基或类似物;R2是卤素原子,氰基或类似物;n是0到4的整数;R3是羟基,卤素原子或类似物;A1是C(R11R12);A2是C(R13R14)或C═O;A3是C(R15R16);R11、R12、R13、R14、R15和R16分别独立地是氢原子或C1-6烷基基团。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-